AHR Stock Forecast 2025-2026
Distance to AHR Price Targets
AHR Price Momentum
10 Quality Stocks Worth Considering Now
Researching American Healthcare REIT (AHR) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on AHR and similar high-potential opportunities.
Latest AHR Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, AHR has a bullish consensus with a median price target of $34.00 (ranging from $30.00 to $37.00). Currently trading at $31.08, the median forecast implies a 9.4% upside. This outlook is supported by 7 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Ronald Kamdem at Morgan Stanley, projecting a 19.0% upside. Conversely, the most conservative target is provided by Michael Carroll at RBC Capital, suggesting a 3.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AHR Analyst Ratings
AHR Price Target Range
Latest AHR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AHR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 31, 2025 | Keybanc | Austin Wurschmidt | Overweight | Maintains | $34.00 |
| Mar 25, 2025 | Morgan Stanley | Ronald Kamdem | Overweight | Maintains | $37.00 |
| Mar 19, 2025 | RBC Capital | Michael Carroll | Outperform | Reiterates | $34.00 |
| Mar 4, 2025 | Citizens Capital Markets | Aaron Hecht | Market Outperform | Maintains | $35.00 |
| Dec 30, 2024 | Morgan Stanley | Ronald Kamdem | Overweight | Maintains | $29.00 |
| Nov 18, 2024 | RBC Capital | Michael Carroll | Outperform | Maintains | $30.00 |
| Nov 15, 2024 | Truist Securities | Michael Lewis | Buy | Maintains | $29.00 |
| Sep 24, 2024 | B of A Securities | Joshua Dennerlein | Buy | Maintains | $31.00 |
| Sep 20, 2024 | JMP Securities | Aaron Hecht | Market Outperform | Maintains | $30.00 |
| Sep 20, 2024 | Truist Securities | Michael Lewis | Buy | Maintains | $27.00 |
| Sep 20, 2024 | Keybanc | Austin Wurschmidt | Overweight | Maintains | $28.00 |
| Sep 16, 2024 | Keybanc | Austin Wurschmidt | Overweight | Maintains | $27.00 |
| Sep 3, 2024 | Truist Securities | Michael Lewis | Buy | Maintains | $22.00 |
| Aug 22, 2024 | Morgan Stanley | Ronald Kamdem | Overweight | Maintains | $22.00 |
| Aug 20, 2024 | B of A Securities | Joshua Dennerlein | Buy | Maintains | $27.00 |
| Aug 8, 2024 | B of A Securities | Buy | Maintains | $19.00 | |
| Aug 7, 2024 | JMP Securities | Aaron Hecht | Market Outperform | Maintains | $18.00 |
| Jul 1, 2024 | Truist Securities | Michael Lewis | Buy | Reiterates | $17.00 |
| May 16, 2024 | JMP Securities | Aaron Hecht | Market Outperform | Reiterates | $16.00 |
| Apr 3, 2024 | Truist Securities | Michael Lewis | Buy | Maintains | $16.00 |
American Healthcare REIT Inc. (AHR) Competitors
The following stocks are similar to American Healthcare REIT based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
American Healthcare REIT Inc. (AHR) Financial Data
American Healthcare REIT Inc. has a market capitalization of $4.93B with a P/E ratio of -107.2x. The company generates $2.06B in trailing twelve-month revenue with a -1.8% profit margin.
Revenue growth is +12.1% quarter-over-quarter, while maintaining an operating margin of +6.8% and return on equity of -1.9%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
American Healthcare REIT Inc. (AHR) Business Model
About American Healthcare REIT Inc.
Invests in healthcare-related real estate properties.
The company operates as a real estate investment trust (REIT) focused on acquiring, owning, and managing healthcare properties, generating revenue primarily through stable rental income from tenants such as healthcare providers. Its strategic emphasis on high-quality and well-located properties supports ongoing demand in the healthcare sector.
American Healthcare REIT Inc. addresses the increasing need for medical and wellness facilities due to demographic trends, particularly the aging population. Its investments not only yield economic returns but also contribute significantly to the healthcare infrastructure and community well-being across the U.S.
Company Information
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Employees
114
CEO
Mr. Danny Prosky
Country
United States
IPO Year
2024
Website
www.americanhealthcarereit.comAmerican Healthcare REIT Inc. (AHR) Latest News & Analysis
Latest News
American Healthcare REIT Announces Dates for First Quarter 2025 Earnings Release and Conference Call
21 days agoAmerican Healthcare REIT, Inc. (NYSE: AHR) will release its Q1 2025 earnings on May 8, 2025, after market close.
The scheduled earnings release may impact American Healthcare REIT's stock price, as investors will assess financial performance and outlook, influencing market sentiment and investment decisions.
State Of REITs: The 'Dark Age' Is Over
28 days agoU.S. REITs have outperformed major benchmarks amid a market correction, following three years of underperformance. The number of publicly listed REITs continues to decline, indicating low institutional interest.
The underperformance of REITs relative to major benchmarks highlights potential investment opportunities, especially as they rebound while equities struggle, indicating a shift in market dynamics.
American Healthcare REIT reported 8.5% same-store growth and a 21.6% increase in Q4 2024 Net Operating Income. Valuation suggests a $30 share value, indicating a 0.54% upside. Rating: "hold."
American Healthcare REIT's strong growth metrics and favorable valuation signal stability and potential returns, making it a key consideration for income-focused investors amid demographic trends.
American Healthcare REIT, Inc. (NYSE: AHR) has declared a quarterly distribution of $0.25 per share for the quarter ending March 31, 2025.
The quarterly distribution indicates financial stability and a commitment to returning value to shareholders, which can positively influence stock performance and investor confidence.
Demographic trends, such as an aging population, drive REIT performance. Chilton targets single-family rental and healthcare REITs, benefiting firms like Welltower and Ventas.
Demographic shifts impact REIT performance, guiding sector allocations. Increased demand for senior housing and healthcare facilities favors specific REITs, indicating potential growth areas for investors.
American Healthcare REIT, Inc. (NYSE:AHR) will host its Q4 2024 earnings conference call on February 28, 2025, at 1:00 PM ET. Key executives and analysts will participate.
The earnings call for American Healthcare REIT provides insights into the company's financial health and future strategies, influencing investor sentiment and stock performance in the healthcare real estate sector.
Frequently Asked Questions About AHR Stock
What is American Healthcare REIT Inc.'s (AHR) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, American Healthcare REIT Inc. (AHR) has a median price target of $34.00. The highest price target is $37.00 and the lowest is $30.00.
Is AHR stock a good investment in 2025?
According to current analyst ratings, AHR has 7 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $31.08. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AHR stock?
Wall Street analysts predict AHR stock could reach $34.00 in the next 12 months. This represents a 9.4% increase from the current price of $31.08. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is American Healthcare REIT Inc.'s business model?
The company operates as a real estate investment trust (REIT) focused on acquiring, owning, and managing healthcare properties, generating revenue primarily through stable rental income from tenants such as healthcare providers. Its strategic emphasis on high-quality and well-located properties supports ongoing demand in the healthcare sector.
What is the highest forecasted price for AHR American Healthcare REIT Inc.?
The highest price target for AHR is $37.00 from Ronald Kamdem at Morgan Stanley, which represents a 19.0% increase from the current price of $31.08.
What is the lowest forecasted price for AHR American Healthcare REIT Inc.?
The lowest price target for AHR is $30.00 from Michael Carroll at RBC Capital, which represents a -3.5% decrease from the current price of $31.08.
What is the overall AHR consensus from analysts for American Healthcare REIT Inc.?
The overall analyst consensus for AHR is bullish. Out of 10 Wall Street analysts, 7 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $34.00.
How accurate are AHR stock price projections?
Stock price projections, including those for American Healthcare REIT Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.